Articles tagged "Kidney transplantation"

2021 American Transplant Congress
Outcomes in Standard vs. Extended Use of Thymoglobulin as Induction Therapy in Kidney Transplant Recipients
N. M. Sifontis¹, A. Coleman¹, D. Tang¹, K. Lau², S. Karhadkar², A. DiCarlo², A. Diamond²
¹Temple University School of Pharmacy, Philadelphia, PA, ²Temple University Health System, Philadelphia, PA
*Purpose: Thymoglobulin induction along with modern maintenance immunosuppression has been found to have a significant reduction in acute rejection in kidney transplantation. The recommended duration…
2021 American Transplant Congress
Different Levels of GFR of Retained Kidney on the Long-term Safety of the Donors in Living-related Renal Transplantation
M. Dou, P. Tian, B. Zheng, G. Deng, Y. Shi, C. Ding
The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
*Purpose: To summarize the long-term safety of different levels of GFR of retained kidney among living-related donors.Health status,postoperative recovery,and postoperative complications were compared and analyzed.*Methods:…
2021 American Transplant Congress
Preempting Misconceptions: An Educational Initiative for Preemptive Kidney Transplant Candidates
T. Menser¹, M. Hobeika², H. Ibrahim², A. Khan¹, B. Cruz², J. Sharp², A. Gaber²
¹Houston Methodist Research Institute, Houston, TX, ²Houston Methodist Hospital, Houston, TX
*Purpose: reemptive living donor kidney transplantation (pLDKT) offers many advantages for patients with advanced chronic kidney disease. However, pLDKT represents less than 1 out of…
2021 American Transplant Congress
Impact of Once-Daily Extended-Release Tacrolimus Intrapatient Variability in Stable Adolescent and Young Adult Renal Transplant Recipients – 3 Year Results
M. M. Chandran¹, E. Blanchette¹, J. Goebel², M. Bock¹
¹Children's Hospital Colorado, Denver, CO, ²Helen DeVos Children’s Hospital, Grand Rapids, MI
*Purpose: Successful renal transplantation requires complex medication regimens that rely heavily on strict adherence to be effective. Variability in immunosuppression exposure, specifically tacrolimus, is associated…
2021 American Transplant Congress
Graft Outcomes of Antibody Mediated Rejection without Donor Specific Anti – HLA Antibodies After Kidney Transplantation
H. Ko, S. Min, A. Han, S. Ahn, C. T. Chung, H. Kim, K. Choi, S. Min, H. Kang, J. Ha
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study was to investigate graft outcomes based on the presence of donor-specific anti-HLA antibodies (DSA) and the time of diagnosis…
2021 American Transplant Congress
Changes in Glomerular Filtration Rate (delta Egfr) within the First Year Predict Long-Term Outcomes of Renal Grafts
A. M. Thompson, M. Zenati, S. Hariharan, M. Molinari
Starzl Transplant Institute, UPMC, Pittsburgh, PA
*Purpose: The relationship between changes in eGFR (Delta eGFR) during the first year after renal transplantation (RT) and long-term graft survival are poorly understood. We…
2021 American Transplant Congress
Review of Outcomes After Diagnosis of Malignancy in Kidney Transplant Patients: Unos Database
H. Patel¹, N. Agrawal¹, R. Gupta¹, P. Geetha², A. Abdul Razzack³, F. Cardarelli¹
¹Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ²Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ³Medicine, Dr. NTR University of Health Sciences, Vijaywada, India
*Purpose: Malignancy is the third major cause of death among transplant recipients. Among the transplant recipients, Patient and kidney transplant outcomes after the diagnosis of…
2021 American Transplant Congress
Transplant Data Platform – An Augmented Clinical Intelligence Framework
C. Focht, W. Tian, J. Zeng, N. Dzebisashvili, S. Ghosh
CareDx, Brisbane, CA
*Purpose: UNOS, SRTR, USRDS registries are rich in patient baseline data. However, all suffer from data attrition as patients move further out post-transplant or between…
2021 American Transplant Congress
Kidney Transplantation in Times of Covid-19 – Decision Analysis in the Canadian Context
I. Yanev¹, M. Gagnon¹, M. Cheng², S. Paraskevas², D. Kumar³, A. Dragomir⁴, R. Sapir-Pichhadze⁴
¹McGill University, Montreal, QC, Canada, ²McGill University Health Centre, Montreal, QC, Canada, ³University Health Network, Toronto, ON, Canada, ⁴Research Institute of McGill University Health Centre, Montreal, QC, Canada
*Purpose: The coronavirus disease 2019 (COVID-19) pandemic significantly impacted the field of transplantation across Canada. In this study, we outline the implications of COVID-19 related…
2021 American Transplant Congress
Kidney Transplantation in Very Highly-Sensitized Patients with Maastricht Type III Non-heart-Beating Donors
F. Villanego¹, A. Mazuecos¹, L. Vigara¹, V. Lopez², G. Bernal³, A. Rodriguez-Benot⁴, M. de Gracia⁵, P. Castro⁶, A. Alvarez⁶
¹Department of Nephrology, Hospital Puerta del Mar, Cadiz, Spain, ²Department of Nephrology, Hospital Carlos Haya, Malaga, Spain, ³Department of Nephrology, Hospital Virgen del Rocio, Sevilla, Spain, ⁴Department of Nephrology, Hospital Reina Sofia, Cordoba, Spain, ⁵Department of Nephrology, Hospital Virgen de las Nieves, Granada, Spain, ⁶Andalusian Transplant Coordination, Sevilla, Spain
*Purpose: In 2012, a kidney transplant (KT) program for very highly-sensitized (VHS) patients (PRA ≥ 95%) based on virtual crossmatch began in Andalusia (Spanish region).…